Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/1996
10/24/1996WO1996032965A1 Cd45rb binding compounds for the prevention of transplant rejection
10/24/1996WO1996032961A1 Compositions and methods for regulating hair growth
10/24/1996WO1996032960A1 Preventive and/or remedy for ischemic diseases
10/24/1996WO1996032959A1 Cns neurite outgrowth modulators, and compositions, cells and methods embodying and using same
10/24/1996WO1996032958A1 Method for treatment of pain
10/24/1996WO1996032957A1 Modulation of cytokine patterns of human autoreactive t-cell clones
10/24/1996WO1996032956A1 p19: A CELL CYCLE INHIBITOR
10/24/1996WO1996032955A1 Neuropeptide y analogs
10/24/1996WO1996032954A1 Nitrosylated neuropeptides
10/24/1996WO1996032946A1 Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
10/24/1996WO1996032932A1 Dna vaccines against rotavirus infections
10/24/1996WO1996032841A1 Novel therapeutic binding molecule complexes
10/24/1996WO1996020278A3 Genetically engineered human-derived kunitz domains that inhibit human neutrophil elastase
10/24/1996WO1996017953A3 Genetic basis of factor xiii activity
10/24/1996WO1996016982A3 Ultraselective opioidmimetic peptides and pharmacological and therapeutic uses thereof
10/24/1996WO1996011562A3 Human checkpoint gene and gene for antisense rna thereof
10/24/1996DE19515327A1 Antitumour agents comprising new poly:peptide(s)
10/24/1996CA2218864A1 Agent for preventing and/or treating ischemic diseases
10/24/1996CA2218716A1 N-aroylamino acid amides as endothelin inhibitors
10/24/1996CA2218691A1 Novel therapeutic binding molecule complexes
10/24/1996CA2218618A1 Method for treatment of pain
10/24/1996CA2218610A1 An adenovirus helper-virus system
10/24/1996CA2218606A1 Novel peptide derivatives
10/24/1996CA2218599A1 Cns neurite outgrowth modulators, and compositions, cells and methods embodying and using same
10/24/1996CA2218585A1 H. influenzae hxub and hxuc genes, proteins and methods of use
10/24/1996CA2218522A1 Multiple administrations of anti-tnf antibody
10/24/1996CA2218418A1 Recombinant preduodenal lipases and polypeptide derivatives produced by plants, processes for obtaining them and their uses
10/24/1996CA2218389A1 Peptidyl derivatives as inhibitors of pro-apoptotic cysteine proteinases
10/24/1996CA2217865A1 Efflux pump inhibitors
10/24/1996CA2217496A1 Protective helicobacter antigens
10/24/1996CA2216936A1 Modulation of cytokine patterns of human autoreactive t-cell clones
10/24/1996CA2216868A1 High efficiency ex vivo transduction of hematopoietic stem cells by recombinant retroviral preparations
10/24/1996CA2216751A1 Conotoxin peptides
10/24/1996CA2215991A1 Method for preparing streptogramines
10/24/1996CA2215631A1 Arteriovenous and venous graft treatments: methods and compositions
10/24/1996CA2215264A1 Tumor protease activated prodrugs of phosphoramide mustard analogs
10/23/1996EP0738736A1 Monoclonal antibodies to gp130, and their uses
10/23/1996EP0738734A1 NOVEL RECOMBINANT DerI ALLERGENIC SUBSTANCE, PRECURSOR THEREOF, AND PROCESS FOR PRODUCING THEM
10/23/1996EP0738516A1 External preparation for skin protection
10/23/1996EP0738512A1 Use of a HMG CoA reductase inhibitor to prevent a second heart attack
10/23/1996EP0738329A1 Hybrid cytokines
10/23/1996EP0738328A1 Composition containing nucleic acids, preparation and uses
10/23/1996EP0738327A1 Host-vector system for use in gene therapy
10/23/1996EP0738324A1 Synergistic antifungal protein and compositions containing same
10/23/1996EP0738323A1 Thrombopoietin
10/23/1996EP0738322A1 T cell antigen receptor v region proteins and methods of preparation thereof
10/23/1996EP0738321A1 Association of kinesin with sensitivity to chemotherapeutic drugs
10/23/1996EP0738320A1 Synthetic antimicrobial peptides
10/23/1996EP0738281A1 Peptides and methods against psoriasis
10/23/1996EP0738280A1 Superactive vip antagonists
10/23/1996EP0738279A1 Novel bone and prostate-derived protein factors affecting prostate cancer growth, differentiation, and metastasis
10/23/1996EP0738278A1 Expression of surface layer proteins
10/23/1996EP0738277A1 Novel proteins which bind to retinoblastoma protein and their encoding dna sequences
10/23/1996EP0738158A1 Biological targeting agents
10/23/1996EP0738156A1 Methods and compositions for inhibiting thrombogenesis
10/23/1996EP0738155A1 Modular design and synthesis of oxazolone-derived molecules
10/23/1996EP0738154A1 N-terminus modified analogs of lhrh
10/23/1996EP0640143A4 Senescent cell derived inhibitors of dna synthesis.
10/23/1996EP0629213B1 Use of an immunostimulatory agent
10/23/1996EP0593491B1 Luteinizing hormone releasing hormone antagonist peptides
10/23/1996EP0536231B1 A process for the preparation of glutathione s-acyl derivatives and compounds obtained from said process
10/23/1996EP0528886B1 Beta cell antigen
10/23/1996EP0480060B1 S-(lower fatty acid)-substituted glutathione derivative
10/23/1996EP0469156B1 Glutathione derivative
10/23/1996EP0422125B1 Platelet blocking peptides
10/23/1996EP0276262B1 Merozoite surface antigen of plasmodium falciparum
10/23/1996CN1134174A Modified plant viruses as vectors of heterologous peptides
10/23/1996CN1134172A Protocadherin proteins and their uses
10/23/1996CN1134157A Process for preparation of virus-inactivated factor VIII-contg. fraction by chromatographic methods
10/23/1996CN1134152A Substd. thiazolo|3.2-alpha¨ azepine deriv.
10/23/1996CN1134148A Antithrombotic amidinophenylalanine and amidinopyridylalanine derivs
10/23/1996CN1134113A Method for inducing antigen-specific T cell tolerance
10/23/1996CN1134111A Method of using insulin-like growth factor binding proteins
10/23/1996CN1134110A Method for regulating gastrointestinal motility
10/23/1996CN1134109A Chemically-defined non-polymeric valency plateform molecules and conjugates thereof
10/23/1996CN1133886A Method for obtaining modified immunoglobulins with reduced immunogenicity of murine antibody variable domains and compositions containing them
10/23/1996CN1133885A Preparation of alpha-1 antichymotrypsin
10/22/1996US5567814 2-substituted indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ACE
10/22/1996US5567807 Using an anionic exchange resin
10/22/1996US5567805 The cellular receptor for the CS3 peptide of human immunodeficiency virus
10/22/1996US5567804 Human leucocyte elastase inhibitor; antioxidant
10/22/1996US5567803 Anti-obesity proteins
10/22/1996US5567682 Method of treating Alzheimer's disease
10/22/1996US5567681 PGLa and XPF peptides and uses therefor
10/22/1996US5567679 Use of CGRP in treating alopecia
10/22/1996US5567678 Anti-obesity proteins
10/22/1996US5567677 Protein formulation comprising growth hormone
10/22/1996US5567676 Bactericides
10/22/1996US5567609 Antigrowth agents
10/22/1996US5567604 Anti-viral guanosine-rich oligonucleotides
10/22/1996US5567597 Hydrolytic enzyme inhibitors/inactivators and methods for using same
10/22/1996US5567592 Identifying compounds useful for increasing bioavailability of drug in mammal
10/22/1996US5567584 Methods of using biologically active dimerized polypeptide fusions to detect PDGF
10/22/1996US5567582 Dna sequences
10/22/1996US5567435 Mixing active material with a solution of polymerizable macromer comprising degradable region and free radical polymerizable end groups
10/22/1996US5567423 Animal growth promotant
10/22/1996US5567417 Method for inhibiting angiogenesis using heparinase
10/22/1996US5567408 YIGSR peptide radiopharmaceutical applications
10/22/1996CA2021767C Method for preparing a pharmaceutical composition in the form of microparticles
10/22/1996CA1338663C Biosynthetic osteogenic proteins and osteogenic devices containing them
1 ... 2759 2760 2761 2762 2763 2764 2765 2766 2767 2768 2769 2770 2771 2772 2773 2774 2775 2776 2777 2778 2779 ... 3163